• Careers
Contact

Mansfield is a leading healthcare and life sciences strategy consulting firm as ranked by the Financial Times and Vault

We advise on corporate strategy, value creation and commercial due diligence by combining research, modelling and analysis with clinical, scientific and operational knowledge

Selected Clients and Assets we have worked on

Our Latest Insights

Expert analysis across healthcare, life sciences, pharma, social care and digital

A Healthcare Investor’s Guide to “AI Exposure”
A Healthcare Investor’s Guide to “AI Exposure”
Investment
Pet Food 2036: Growth and Disruption in Cat and Dog Food
Pet Food 2036: Growth and Disruption in Cat and Dog Food
Animal Health
Radiopharmaceuticals – where hot molecules meet cold capital
Radiopharmaceuticals – where hot molecules meet cold capital
Therapeutic Products and Innovation
GLP-1 2.0: Where the next wave of value will be created
GLP-1 2.0: Where the next wave of value will be created
Therapeutic Products and Innovation
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Health & Care
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Investment
Will primary care always be secondary for investors?
Will primary care always be secondary for investors?
Health & Care
Three key lessons for digital health investors from the demise of Babylon Health
Three key lessons for digital health investors from the demise of Babylon Health
Health & Care
A Quick Update on NHS Waiting Lists
A Quick Update on NHS Waiting Lists
Health & Care
The Evolving Roles of CDMOs
The Evolving Roles of CDMOs
Investment
View all

News & Insights

Healthcare news, data and analysis

Via Investors in Healthcare

Amulet Capital Partners, a mid-market PE firm focused on healthcare, has acquired TFP Fertility Group, one of the leading fertility care providers in the UK and Northern Europe, from Benefit […]
UK: Amulet acquires TFP Fertility Group from Benefit Street
8 May 2026
Buy Out ,
Fertility ,
Healthcare ,
M&A ,
News
Long standing CEO at The London Clinic, Al Russell, is stepping down from his role in autumn after almost a decade. He will be replaced by Philip Luce. The London […]
UK: Al Russell stepping down from CEO role at The London Clinic to be replaced by Philip Luce
8 May 2026
Healthcare ,
Hospitals and Clinics ,
News ,
People ,
Al Russell
Angelini Pharma, the Italy-based international pharmaceutical company and part of the Angelini Industries Group, is entering the US market with the acquisition of Nasdaq-listed Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company […]
Italy: Angelini Pharma to enters US market and consolidates leadership in brain health with acquisition of Catalyst Pharmaceuticals for US$4.1bn
8 May 2026
M&A ,
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Akerman
Linimed Gruppe, a leading provider of community‑based intensive care services in Germany, has secured capital from funds managed by Ares Management. “Partnering with Ares marks an important milestone in Linimed’s […]
Germany: Ares invests in Linimed to support growth strategy in intensive community care and rehabilitation therapy services
7 May 2026
Homecare ,
News ,
Social Care ,
Venture ,
Ares Management
Jeito Capital has reached a major milestone with the final close of Jeito II at €1bn (US$1.2bn), marking the largest fundraise to date for a fully independent biopharma-focused venture fund […]
Jeito Capital scales up to back Europe’s clinical-stage biopharma leaders
7 May 2026
Analysis ,
News ,
Pharma ,
Venture ,
France
Baird Capital, the global venture capital, growth equity and private equity investor, has closed an oversubscribed continuation vehicle to support Blue Matter Consulting, a consulting firm serving the life sciences […]
UK: Baird Capital closes continuation fund to support further growth of Blue Matter
6 May 2026
Buy Out ,
Life Sciences ,
News ,
Venture ,
Ares Secondaries
Fresenius, a global, therapy-focused healthcare company, together with SAP, is investing in Avelios Medical, a Munich-based company developing a next-generation, cloud-native hospital information system. The deal builds on the partnership […]
Germany: Fresenius invests in Avelios Medical and further expands its strategic partnership with SAP
6 May 2026
Digital Health/Healthtech ,
Healthcare ,
Life Sciences ,
Medtech – Healthcare IT ,
News
Columna Capital has acquired a majority stake in Evidenze Group, a Spain‑based full‑service CRO, from Buenavista Equity Partners. The UK‑based pan‑European lower mid‑market investor is partnering with Evidenze co‑founders Pedro […]
Spain: Columna Capital acquires majority stake in Evidenze Group from Buenavista Equity Partners
5 May 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – CRO/CMO/CDMO
Jeito Capital, a France-based global independent private equity fund dedicated to Biopharma, has appointed Elaine Caughey as partner, business development and investor relations, and Sarah Shackelton as partner, talent. With […]
France: Jeito bolsters leadership team with Elaine Caughey and Sarah Shakleton
5 May 2026
News ,
People ,
Pharma ,
Elaine Caughey ,
France
Atlas Health, a private equity fund established to invest in European Healthcare companies, has held an oversubscribed final close of its debut fund, Atlas Health Fund I, at its £400m […]
UK: Atlas Health holds final close of debut Atlas Health Fund I at £400m hard cap
5 May 2026
Animal Health ,
Life Sciences ,
Manufacturing – Specialty Pharma ,
Medtech – Diagnostics ,
Medtech – Healthcare IT
Stockholm-listed, Sweden-based international healthcare and diagnostic services company, Medicover, has signed a new €450m (US$526m) syndicated revolving credit facility agreement. The new facility replaces the existing €300m revolving credit facility […]
Sweden: Medicover signs €450m syndicated revolving credit facility
5 May 2026
Debt ,
Diagnostics ,
Healthcare ,
News ,
Bank Pekao
Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, is to acquire Candid Therapeutics, a US-based privately held clinical-stage biotechnology company redefining the treatment of autoimmune […]
Belgium: UCB expanding capabilities in next‑generation biologics with acquisition of Candid Therapeutics
5 May 2026
M&A ,
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Belgium
Artificial intelligence is already reshaping workflows and productivity across all industries. The implications for value creation, however, are far from uniform. Filippos Papadopoulos, senior analyst, Seren Marsh, clinical fellow, and […]
A healthcare investor’s guide to “AI exposure”
5 May 2026
Analysis ,
Healthcare ,
Life Sciences ,
News ,
Pharma
Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, has acquired the Patients Insights business of IMIDomics, a US-based biotechnology company focused on drug discovery […]
Belgium: UCB strengthens in IMIDs with acquisition of IMIDomics’ Patient Insight business
1 May 2026
M&A ,
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Alistair Henry
New York-listed Lazard, a global financial advisory and asset management firm, is acquiring Campbell Lutyens, a UK-based global private markets advisor focused on fund placement, secondary advisory, and GP capital […]
UK: Lazard acquisition of Campbell Lutyens to create leading global Private Capital Advisory
1 May 2026
M&A ,
News ,
Campbell Lutyens ,
Gordon Bajnai ,
Holcombe Green
Greenpeak Partners‑backed athagoras, a Germany‑based platform of life sciences consultants, has added Ecker + Ecker and Accessus Health to the group, representing a clear move toward a leading position in […]
Germany: Greenpeak-backed athagoras adds Ecker + Ecker and Accessus Health to growing network of consultants
1 May 2026
Buy Out ,
M&A ,
News ,
Pharma ,
Services – Medical Communications
Demetra,  an Italy-based independent medical company providing anti-infective cements, spacers and biomaterials for orthopaedic applications, has acquired Maxxspine Innovative, a German-based company specialising in advanced spinal surgery solutions. The transaction strengthens […]
Germany: Demetra strengthens its position in spine surgery with acquisition of Maxxspine Innovative
30 April 2026
Life Sciences ,
M&A ,
Medtech – Medical Devices and Implants ,
News ,
Demetra
Chiesi Group, an Italy-based, family-controlled, international research-focused biopharmaceutical group and certified B Corp, is acquiring Nasdaq-listed KalVista Pharmaceuticals, a global pharmaceutical company focused on addressing the critical unmet needs of […]
Italy: Chiesi Group expanding global Rare Disease portfolio with US$1.9bn acquisition of KalVista
30 April 2026
M&A ,
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Ben Palleiko
Archimed Diagnostics – the diagnostics team of France‑based global healthcare private equity specialist Archimed – has acquired Stago, a world leader in haemostasis analysis. Stago, headquartered in France, develops and […]
France: Stago accelerating growth with Archimed and La Caisse
29 April 2026
Buy Out ,
IVD – Tools ,
Life Sciences ,
M&A ,
Medtech – Diagnostics
NIB, the international financial institution of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, and Sweden, has signed an ISK4.4bn (US$36m) 10-year indexed loan with the listed Icelandic real estate company Reitir hf. The loan will […]
Iceland: NIB finances nursing home and healthcare facilities in Reykjavik 
29 April 2026
Care Homes ,
Debt ,
Healthcare ,
Hospitals and Clinics ,
News
vVardis Holding, a Switzerland-based dental medtech company pioneering non-invasive cavity treatment, has achieved unicorn status following a strategic minority investment from US-based Apollo-managed funds. The investment establishes vVardis as one […]
Switzerland: vVardis reaches unicorn status following investment from Apollo
29 April 2026
Dental ,
Healthcare ,
News ,
Venture ,
Andrea Vanni
Echosens, a France-based specialist diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases, has appointed Romain Baujard as group […]
France: Echosens appoints Romain Baujard as group CEO
28 April 2026
Diagnostics ,
Healthcare ,
News ,
People ,
Astorg
Salt Capital, a private equity investment firm focused on growth capital investments in the SADC region, and Proparco, the French Development finance institution, have acquired The Namibian Oncology Centre (NOC), […]
Namibia: Salt Capital and Proparco acquire The Namibian Oncology Centre
28 April 2026
Buy Out ,
Healthcare ,
Hospitals and Clinics ,
M&A ,
M&A Deals
UK-based business challenger bank, Allica Bank, is announced it is expanding its lending and product flexibility in support of UK healthcare operators. The changes enable the bank to better support […]
UK: Allica Bank expands lending and products in support of healthcare businesses
28 April 2026
Debt ,
Healthcare ,
News ,
Allica Bank ,
Anthony Newman
Astorg, a pan European private equity firm, has signed a definitive agreement to acquire New York-listed Thermo Fisher Scientific’s microbiology business for approximately US$1.075bn, consisting of cash and a US$50m […]
Luxembourg: Astorg to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn
27 April 2026
Buy Out ,
Life Sciences ,
M&A ,
Medtech – Diagnostics ,
News